Heparin is monitored by measuring the APTT.
For established thromboembolism, the APTT should be prolonged 1.5 - 2.0 times normal. The therapeutic response lessens if the APTT is less than 1.5 times normal.
Bleeding risk at this level is low unless there are predisposing risk factors. High risk patients should be treated at the lower end of the range.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.